CXCL13 and inflammatory bowel disease: There is also strong evidence for non-canonical activation with increased expression of the activators lta and ltb and increased expression of genes for the known downstream chemokine cxcl13 that is linked to non-canonical NF-κB activation in human IBD patients [48].